DK0595888T3 - Fremgangsmåde til fremstilling af demethylepipodophyllotoxin - Google Patents

Fremgangsmåde til fremstilling af demethylepipodophyllotoxin

Info

Publication number
DK0595888T3
DK0595888T3 DK92915482.1T DK92915482T DK0595888T3 DK 0595888 T3 DK0595888 T3 DK 0595888T3 DK 92915482 T DK92915482 T DK 92915482T DK 0595888 T3 DK0595888 T3 DK 0595888T3
Authority
DK
Denmark
Prior art keywords
demethylepipodophyllotoxin
beta
alkylidene
react
ester
Prior art date
Application number
DK92915482.1T
Other languages
English (en)
Inventor
Pietro Allevi
Mario Anastasia
Ettore Bigatti
Peter Macdonald
Original Assignee
Sicor Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11360401&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0595888(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sicor Spa filed Critical Sicor Spa
Application granted granted Critical
Publication of DK0595888T3 publication Critical patent/DK0595888T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK92915482.1T 1991-07-23 1992-07-15 Fremgangsmåde til fremstilling af demethylepipodophyllotoxin DK0595888T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI912025A IT1250692B (it) 1991-07-23 1991-07-23 Procedimento per la preparazione di demetilepipodofillotossina- beta-d-glucosidi.

Publications (1)

Publication Number Publication Date
DK0595888T3 true DK0595888T3 (da) 1998-05-18

Family

ID=11360401

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92915482.1T DK0595888T3 (da) 1991-07-23 1992-07-15 Fremgangsmåde til fremstilling af demethylepipodophyllotoxin

Country Status (16)

Country Link
US (1) US5688925A (da)
EP (1) EP0595888B1 (da)
JP (1) JP3231765B2 (da)
AT (1) ATE159026T1 (da)
AU (1) AU666322B2 (da)
CA (1) CA2113894C (da)
DE (1) DE69222643T2 (da)
DK (1) DK0595888T3 (da)
ES (1) ES2107546T3 (da)
FI (1) FI110782B (da)
GR (1) GR3025729T3 (da)
IL (1) IL102610A (da)
IT (1) IT1250692B (da)
MX (1) MX9204334A (da)
WO (1) WO1993002094A1 (da)
ZA (1) ZA925515B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2191733T3 (es) * 1995-12-04 2003-09-16 Nippon Kayaku Kk Procedimiento para producir etoposido.
WO1998055491A1 (en) * 1997-06-02 1998-12-10 Bristol-Myers Squibb Company Process for preparing etoposide
CA2343803A1 (en) * 1998-09-10 2000-03-23 Ragina Naidu Synthetic method for the preparation of the antineoplastic agent etoposide
FR2791681B1 (fr) * 1999-03-29 2001-06-22 Pf Medicament Nouveau procede de preparation de l'etoposide
GB0019124D0 (en) * 2000-08-03 2000-09-27 Pfizer Novel process
AU2006207321B2 (en) 2005-01-21 2012-09-06 Astex Therapeutics Limited Pharmaceutical compounds
JP5528806B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
WO2008044045A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
ES2673957T5 (es) 2011-10-03 2021-12-15 Croda Int Plc Nanopartículas, procedimiento para la preparación y utilización de las mismas como portadoras de moléculas anfipáticas o hidrofóbicas en el campo de la medicina, incluyendo el tratamiento del cáncer, y compuestos de tipo alimentario
AR095962A1 (es) 2013-04-01 2015-11-25 Moreinx Ab Nanopartículas, compuestas de esterol y saponina de quillaja saponaria molina, proceso para preparación y uso de las mismas como portadores para moléculas anfipáticas o hidrófobas en el campo de la medicina incluyendo tratamiento de cáncer y compuestos relacionados con alimentos
EP3616688A1 (en) 2018-08-27 2020-03-04 Centre National de la Recherche Scientifique - CNRS Preparation of nanosuspension comprising nanocrystals of active pharmaceutical ingredients with little or no stabilizing agents
EP3669890A1 (en) 2018-12-18 2020-06-24 Croda International PLC Filamentous nanoparticles having vaccine adjuvant effect
CN113121618A (zh) * 2021-04-07 2021-07-16 梯尔希（南京）药物研发有限公司 两种依托泊苷杂质的制备方法
CN115197281B (zh) * 2021-04-09 2024-06-14 四川汇宇制药股份有限公司 依托泊苷中间体的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0111058B1 (en) * 1982-11-26 1987-11-04 Nippon Kayaku Kabushiki Kaisha Process for producing 4'-demethyl-epipodophyllotoxin-beta-d-ethylidene-glucoside and acyl-derivative thereof
JPS60246393A (ja) * 1984-05-22 1985-12-06 Nippon Kayaku Co Ltd エトポシドの新規製造法
IL77334A (en) * 1985-12-16 1991-04-15 Univ Bar Ilan Synthesis of 9-epipodophyllotoxin glucoside derivatives and some novel intermediates therefor
DK39886D0 (da) * 1986-01-27 1986-01-27 Hans Goeran Magnusson Hydroxybeskyttelsesgrupper
US4904768A (en) * 1987-08-04 1990-02-27 Bristol-Myers Company Epipodophyllotoxin glucoside 4'-phosphate derivatives
US4965348A (en) * 1989-05-19 1990-10-23 Bristol-Myers Company Dimeric epipodophyllotoxin glucoside derivatives
US5036055A (en) * 1989-06-07 1991-07-30 Bristol-Myers Company Acylated derivatives of etoposide
DE3935016A1 (de) * 1989-10-20 1991-04-25 Behringwerke Ag Glycosyl-etoposid-prodrugs, verfahren zu ihrer herstellung und ihre anwendung in kombination mit funktionalisiertem tumorspezifischen enzym-konjugaten
FR2658824B1 (fr) * 1990-02-27 1992-07-03 Pf Medicament Tris acetyl-2",3",4' ethylidene-4",6" beta-d-glucopyranosides, leur preparation et leur utilisation pour la preparation d'ethylidene beta-d-glucopyranoside de demethyl-4' epipodophyllotoxine.
US5081234A (en) * 1990-04-30 1992-01-14 Bristol-Myers Squibb Co. 4'-demethylepipodophyllotoxin glycosides
CN1025918C (zh) * 1990-06-07 1994-09-14 国家医药管理局上海医药工业研究院 抗肿瘤药表鬼臼毒吡喃糖甙的合成新工艺

Also Published As

Publication number Publication date
ITMI912025A1 (it) 1993-01-24
FI940280A0 (fi) 1994-01-20
FI110782B (fi) 2003-03-31
CA2113894A1 (en) 1993-02-04
AU2326592A (en) 1993-02-23
CA2113894C (en) 2003-12-16
ES2107546T3 (es) 1997-12-01
JPH06509334A (ja) 1994-10-20
ATE159026T1 (de) 1997-10-15
ZA925515B (en) 1993-04-28
EP0595888B1 (en) 1997-10-08
AU666322B2 (en) 1996-02-08
GR3025729T3 (en) 1998-03-31
IL102610A (en) 1997-03-18
EP0595888A1 (en) 1994-05-11
DE69222643T2 (de) 1998-02-05
MX9204334A (es) 1993-02-01
WO1993002094A1 (en) 1993-02-04
JP3231765B2 (ja) 2001-11-26
FI940280A (fi) 1994-01-20
DE69222643D1 (de) 1997-11-13
IT1250692B (it) 1995-04-21
US5688925A (en) 1997-11-18
ITMI912025A0 (it) 1991-07-23

Similar Documents

Publication Publication Date Title
DK0595888T3 (da) Fremgangsmåde til fremstilling af demethylepipodophyllotoxin
EP0411897A3 (en) Avermectin derivatives
CA2006222A1 (en) Enhanced chemiluminescence from 1,2-dioxetanes through energy transfer to tethered fluorescers
BE864250A (fr) Composition a un seul element, activable par application de forces mecaniques et/ou physiques et stable a l'entreposage, et procede pour sa preparation
CA2044619A1 (en) Preparation method for .alpha.,.beta.-unsaturated ketones
DK0799058T3 (da) Forbedringer af eller med hensyn til endometriefunktion
DK386789D0 (da) Fermentor
AU632404B2 (en) Nutrient fluid composition
PT82530B (en) <1,4> benzodioxin and <1,4> benzoxazine derivatives
FR2574184B1 (fr) Composes fluorescents, derives d'(amino-4 disulfonato-3,6) naphtalimide, leur application aux dosages immunologiques en polarisation de fluorescence
IE883358L (en) Ethylated avermectins
JPS5714590A (en) 2-benzyl-5-alkyl-tetrahydro-benzo(b)-1,6-naphthyridin-10-one derivative and its preparation
EA199800918A1 (ru) Происходящие от хозяина сигналы для индуцирования экспрессии гена изопреноида и их применение
IE851486L (en) CYCLOPENTA (b) THIOPHENE-6-CARBOXYLIC ACIDS
KR890000156B1 (en) Hydantoin derivatives
GB2234520B (en) Fuel thermal stability enhancement by chemical deoxygenation
TR199901956T2 (xx) 4H-4-Okso-kinolizin-3-karboksilik asit t�revlerinin haz�rlanmas� i�in bir i�lem.
Madero et al. Altitudinal distribution of the vespids in the Sierra Nevada(Granada, Spain)(Hymenoptera, Vespidae).).
Koehler-Samouilidis Investigations on sensitivity of the microbiological flora of ram semen against antibiotics.
AU6151880A (en) Utility post bracket
JPS53111385A (en) Preparation of 4-methyl-1-pentene polymer composition
ES287391U (es) Colector solar fluorescente integrado en la construccion
ES2019043A6 (es) Procedimiento de preparacion de s-pancopride.
ES2019042A6 (es) Procedimiento de preparacion de r-pancopride.
RO91541B1 (ro) Procedeu de obtinere a alchil-2-hidrxifenil-cetonelor